English
Bayer gets court approval for $7.25 bln Roundup settlement as EPA eyes new science

Bayer noted the agreement is subject to appeal, which would delay payments to plaintiffs. The EPA has steadfastly rejected that classification, and the Trump administration actively backed Bayer in its Supreme Court case.
IARC noted a particular association to non-Hodgkin lymphoma (NHL). President Donald Trump also earlier this year issued an executive order protecting and promoting glyphosate as a critical tool for food production.